A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.

about

A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.

Item

http://www.wikidata.org/entity/Q52812834

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

A United Kingdom Immune Thromb ...... ombopoietin receptor agonists.

@en

A United Kingdom Immune Thrombocytopenia

@nl

type

Item

label

A United Kingdom Immune Thromb ...... ombopoietin receptor agonists.

@en

A United Kingdom Immune Thrombocytopenia

@nl

prefLabel

A United Kingdom Immune Thromb ...... ombopoietin receptor agonists.

@en

A United Kingdom Immune Thrombocytopenia

@nl

P1476

A United Kingdom Immune Thromb ...... rombopoietin receptor agonists

@en

P2093

Adrian Newland

http://www.w3.org/2001/XMLSchema#string

Catherine Bagot

http://www.w3.org/2001/XMLSchema#string

Charlotte Bradbury

http://www.w3.org/2001/XMLSchema#string

Drew Provan

http://www.w3.org/2001/XMLSchema#string

Gillian Evans

http://www.w3.org/2001/XMLSchema#string

Gillian Lowe

http://www.w3.org/2001/XMLSchema#string

Henry G Watson

http://www.w3.org/2001/XMLSchema#string

Jecko Thachil

http://www.w3.org/2001/XMLSchema#string

Kate Talks

http://www.w3.org/2001/XMLSchema#string

Keith Sibson

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.

Toxicities of the thrombopoietic growth factors

Romiplostim or standard of care in patients with immune thrombocytopenia.

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up.

Thrombopoietin receptor agonists: a critical review.

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.

P304

591-594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14395

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Quentin A Hill

J Grainger

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27879997

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia